<DOC>
	<DOCNO>NCT00626938</DOCNO>
	<brief_summary>Sarcoidosis multi-systemic disorder , mean involve organ body clinical presentation highly variable . In 90 % sarcoidosis case lung affect . It difficult give concise definition sarcoidosis due fact exact cause still unknown . Consequently , diagnose disease also rather difficult . Up till , sarcoidosis generally diagnose use general clinical method evaluate status lung include chest X-ray , lung biopsy bronchoalveolar lavage ( BAL ) . However , method consider rather invasive , even important , non-conclusive . Therefore , current study design evaluate use new technique , call SELDI-TOF mass spectrophotometry , diagnosis sarcoidosis . This technique enable analysis enzyme present blood sarcoidosis patient may hopefully lead create disease-specific protein-profile may facilitate recognition sarcoidosis . Moreover , result compare currently use laboratory parameter .</brief_summary>
	<brief_title>Role Proteomics Diagnosing Sarcoidosis</brief_title>
	<detailed_description />
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>Clinical diagnosis pulmonary sarcoidosis stage IIV Nonsmoking No treatment extrapulmonary symptom sarcoidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>sarcoidosis</keyword>
	<keyword>protein profile</keyword>
	<keyword>CYP-450</keyword>
	<keyword>TNF-alpha polymorphism</keyword>
	<keyword>HLA</keyword>
</DOC>